AQVESME

Welcome to the Brand page for “AQVESME”, which is offered here for Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical products for the prevention and treatment of sickle cell disease, pkd and beta thalassemia; pharmaceutical products for the prevention and treatment of rare genetic diseases effecting red blood cells; pharmaceutical products for the prevention and treatment of various anemias;.

Its status is currently believed to be active. Its class is unavailable. “AQVESME” is believed to be currently owned by “Agios Pharmaceuticals, Inc.”